Treatment with UA led to decreased protein expression of angiogenic factors vascular endothelial growth factor (VEGF) and transforming growth factor beta1 (TGF-beta1), both of which are biomarkers associated with cancer cell metastasis. The gene discussed is VEGFA; the disease is cancer.